{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-dominant-alport","columns":[{"gene":"","key":"population-a20fb6bab71fd09640c2","label":"Alport syndrome 3, autosomal dominant","mondoId":"MONDO:0007086","onsetQualifier":null,"originColumnKey":"MONDO:0007086/OMIM:104200","originalViews":[{"key":"MONDO:0007086/OMIM:104200","label":"Alport syndrome 3, autosomal dominant","scopeLabel":"OMIM:104200","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["11063b7d88fe010b978c6228817a0c3b7ecb0efb9fa00f68fd82681f0e99d5a8","11f48f565e6db95559bf5b90ddcf86a5aa0dfe9e5d751f941960b5efbd8cc3f1","292a656916d8c4d154c599578bc646b9912a78ff16bbcbe0b351f1c2f286a90a","2a48048258b13a0152eeb4d5fc06e8690c8e768adeba885f70c2333e44c439d2","2f467654b3f78fe5519cd1135a3d59086314a978eb6a60058b20d0f2d9a60e43","3103b0c0ca1d0dd5782ee7540dd5fd0ea5c8c1b112bc838472059301792ade06","3d444836b40c7f8e8b6e8129b10d71f0f3e9bf44f486dae8d9a6b08c79506575","45fbace5d2fcaf54d1b220145ad96553183f1536869c0f5d895cb8c202c8c701","48bdb15b6e59995a969e8df7149689b5f712341f580fc642047151bffd1a6f4d","7960d115d7ed44a1b3b480852f6555b0827e22c23236e3ce1e4cf2ea5f8f1524","975ebce7c0ff9e7def60ab7800a5fdec8a624d2b0759f95e0cadb1fe2d219e76","976d392684735ff32c3538d10c725b220be2bfa4ca3f69a582577061b637126e","a05959677d4731798be56530d774ee79d6b2495d65b0ce343ec62aa7b4e14949","c4510147bf08d7f53d683f7a3d0d00327aba02402068d4d23b6a2356fa3fad15","c6da5b0372cf3bc2844316bebe89ee2a98150c6f24da81cfdc8510e9374ca6c7","cdb91adb13077e87f98c8d9969b789016e2f346853a5c110845ab0a4ccea3985","dd8cf3cbbae14751d9c34ae11aa2c3f053534a23468571cad940471125890898","fa9d1e870e725c000825d1728f73fb156510332cb7e130faca0142e2e2b6976f","fd2e86ae753b03bf0d132c5f8c5ae5560ef125d2bacda5b2523934b0559cade1"],"recordQualifiers":{},"scopeLabel":"OMIM:104200","sourceIds":["OMIM:104200"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a20fb6bab71fd09640c2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001134","HP:0002157","HP:0030034","HP:0000099","HP:0000365","HP:0000790","HP:0000822"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"omim":15,"published":4}},"features":[{"hpoId":"HP:0001134","label":"Anterior polar cataract","primary":true},{"hpoId":"HP:0002157","label":"Azotemia","primary":true},{"hpoId":"HP:0030034","label":"Glomerular basement membrane lamellation","primary":true},{"hpoId":"HP:0000099","label":"Glomerulonephritis","primary":true},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":true},{"hpoId":"HP:0000790","label":"Hematuria","primary":true},{"hpoId":"HP:0000822","label":"Hypertension","primary":true},{"hpoId":"HP:0002148","label":"Hypophosphatemia","primary":false},{"hpoId":"HP:0001142","label":"Lenticonus","primary":false},{"hpoId":"HP:0002907","label":"Microscopic hematuria","primary":false},{"hpoId":"HP:0000545","label":"Myopia","primary":false},{"hpoId":"HP:0000123","label":"Nephritis","primary":false},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0000100","label":"Nephrotic syndrome","primary":false},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0003774","label":"Stage 5 chronic kidney disease","primary":false},{"hpoId":"HP:0004722","label":"Thickened glomerular basement membrane","primary":false}],"ledeHtml":"Autosomal dominant Alport syndrome is a genetic condition in which the body’s production of type IV collagen is impaired. This collagen is used in the kidney, inner ear, and eye. Symptoms of this disease vary greatly and tend to present in early to late adulthood. Symptoms include blood in the urine, protein in the urine, and gradual loss of kidney function. Less common features include hearing loss, eye lesions, and end stage renal disease. It is caused by changes in either the COL4A3 or COL4A4 gene. Some people with changes in these genes have no symptoms.","mondoId":"MONDO:0007086","node":{"canonicalSlug":"autosomal-dominant-alport","comparisons":[{"documentSha256":"39f029f8c95583122660b3bc2e900ba35931ef49b4b0b004cb1343a565f42702","key":"legacy-alport","kind":"legacy","label":"Alport syndrome","memberIds":["MONDO:0007086","MONDO:0008762","MONDO:0010520","MONDO:0018965","MONDO:0957811"],"mondoId":"MONDO:0018965","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/alport.39f029f8c95583122660b3bc2e900ba35931ef49b4b0b004cb1343a565f42702.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant Alport syndrome","originalSourceId":"ORPHA:88918","paragraphs":["Autosomal dominant Alport syndrome is a genetic condition in which the body’s production of type IV collagen is impaired. This collagen is used in the kidney, inner ear, and eye. Symptoms of this disease vary greatly and tend to present in early to late adulthood. Symptoms include blood in the urine, protein in the urine, and gradual loss of kidney function. Less common features include hearing loss, eye lesions, and end stage renal disease. It is caused by changes in either the COL4A3 or COL4A4 gene. Some people with changes in these genes have no symptoms."],"rawAttribution":"MONDO:0007086","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:19Z","upstream":"GARD:0000624","url":"https://rarediseases.info.nih.gov/diseases/624"},"ownColumnKeys":["population-a20fb6bab71fd09640c2"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal dominant disease","mondoId":"MONDO:0000426","slug":null},{"kind":"parent","label":"Alport syndrome","mondoId":"MONDO:0018965","slug":"alport"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"reported","key":"11063b7d88fe010b978c6228817a0c3b7ecb0efb9fa00f68fd82681f0e99d5a8","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"11f48f565e6db95559bf5b90ddcf86a5aa0dfe9e5d751f941960b5efbd8cc3f1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003774","is_excluded":false,"label":"Stage 5 chronic kidney disease","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"292a656916d8c4d154c599578bc646b9912a78ff16bbcbe0b351f1c2f286a90a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2a48048258b13a0152eeb4d5fc06e8690c8e768adeba885f70c2333e44c439d2","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:11044206","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2f467654b3f78fe5519cd1135a3d59086314a978eb6a60058b20d0f2d9a60e43","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001142","is_excluded":false,"label":"Lenticonus","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3103b0c0ca1d0dd5782ee7540dd5fd0ea5c8c1b112bc838472059301792ade06","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001134","is_excluded":false,"label":"Anterior polar cataract","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3d444836b40c7f8e8b6e8129b10d71f0f3e9bf44f486dae8d9a6b08c79506575","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0030034","is_excluded":false,"label":"Glomerular basement membrane lamellation","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"45fbace5d2fcaf54d1b220145ad96553183f1536869c0f5d895cb8c202c8c701","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"48bdb15b6e59995a969e8df7149689b5f712341f580fc642047151bffd1a6f4d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002157","is_excluded":false,"label":"Azotemia","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"7960d115d7ed44a1b3b480852f6555b0827e22c23236e3ce1e4cf2ea5f8f1524","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"PMID:11044206","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"975ebce7c0ff9e7def60ab7800a5fdec8a624d2b0759f95e0cadb1fe2d219e76","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004722","is_excluded":false,"label":"Thickened glomerular basement membrane","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"976d392684735ff32c3538d10c725b220be2bfa4ca3f69a582577061b637126e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002148","is_excluded":false,"label":"Hypophosphatemia","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a05959677d4731798be56530d774ee79d6b2495d65b0ce343ec62aa7b4e14949","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"PCS","frequency_raw":"1/7","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"PMID:11044206","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c4510147bf08d7f53d683f7a3d0d00327aba02402068d4d23b6a2356fa3fad15","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c6da5b0372cf3bc2844316bebe89ee2a98150c6f24da81cfdc8510e9374ca6c7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000123","is_excluded":false,"label":"Nephritis","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"cdb91adb13077e87f98c8d9969b789016e2f346853a5c110845ab0a4ccea3985","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0002907","is_excluded":false,"label":"Microscopic hematuria","onset_id":null,"reference":"PMID:11044206","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"dd8cf3cbbae14751d9c34ae11aa2c3f053534a23468571cad940471125890898","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000099","is_excluded":false,"label":"Glomerulonephritis","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fa9d1e870e725c000825d1728f73fb156510332cb7e130faca0142e2e2b6976f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fd2e86ae753b03bf0d132c5f8c5ae5560ef125d2bacda5b2523934b0559cade1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:104200","disease_name":"Alport syndrome 3, autosomal dominant","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000100","is_excluded":false,"label":"Nephrotic syndrome","onset_id":null,"reference":"OMIM:104200","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/624\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007086\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0000624</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Autosomal dominant Alport syndrome is a genetic condition in which the body’s production of type IV collagen is impaired. This collagen is used in the kidney, inner ear, and eye. Symptoms of this disease vary greatly and tend to present in early to late adulthood. Symptoms include blood in the urine, protein in the urine, and gradual loss of kidney function. Less common features include hearing loss, eye lesions, and end stage renal disease. It is caused by changes in either the COL4A3 or COL4A4 gene. Some people with changes in these genes have no symptoms.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/624\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-dominant-alport","sourceDocuments":[{"name":"GARD: Autosomal dominant Alport syndrome","reviewed":null,"source_release":"2026-10-25T03:38:19Z","url":"https://rarediseases.info.nih.gov/diseases/624"},{"name":"MONDO: autosomal dominant Alport syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007086"}],"sourceNote":"","synonyms":["Alport syndrome 3, autosomal dominant","Alport syndrome dominant type","Alport syndrome, autosomal dominant","renal failure and sensorineural hearing loss"],"takeawayHtml":"","title":"autosomal dominant Alport syndrome"},"schemaVersion":1}
